Submission of Audited Standalone Financial Results for the quarter and financial year ended March 31, 2026
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Zenotech Laboratories reported a net loss of Rs 107.21 lakhs for FY2026, a sharp decline from profit of Rs 561.29 lakhs in FY2025. Revenue from operations grew marginally by 1.5% to Rs 3,956.20 lakhs. Profit before tax dropped significantly to Rs 418.90 lakhs from Rs 1,069.19 lakhs in the previous year. The company recorded exceptional items of Rs 19.51 lakhs due to Labour Code changes. Tax adjustments were substantial, including MAT credit reversal of Rs 187.47 lakhs and deferred tax charge of Rs 157.82 lakhs. Despite the loss, operating cash flow remained positive at Rs 1,020.48 lakhs. The statutory auditor issued an unmodified (clean) opinion on the financial statements.
The company turned loss-making in FY2026 with PAT negative, primarily due to increased expenses and significant tax reversals. However, strong cash generation and clean audit opinion provide some comfort to shareholders.